BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Pharm Country

  Atara Biotherapeutics To Ring The Nasdaq Stock Market Opening Bell In Celebration Of IPO

  October 16, 2014

   · 

  2 min read
• Deals

  Atara Biotherapeutics Prices IPO Below The Range At $11 A Share

  October 16, 2014

   · 

  2 min read
• Pharm Country

  Regeneron Pharmaceuticals, Inc. Genetics Center Fully Operational, Announces New Collaborations And Key Appointments

  October 16, 2014

   · 

  7 min read
• Drug Development

  Deltanoid Pharmaceuticals, Inc.'s DP001 (2MD) Pharmaceutical Demonstrated Safe And Effective In Kidney Failure Patients On Dialysis

  October 16, 2014

   · 

  3 min read
• Drug Development

  Chimerix, Inc. Provides Update On Research and Development Progress; FDA OKs Brincidofovir In Phase 2 For Ebola Virus Disease

  October 16, 2014

   · 

  4 min read
• Epigenomics AG Raises USD 5.3 Million From Its Strategic Commercialization Partner Biochain Institute, Inc.

  October 16, 2014

   · 

  3 min read
• Portage Completes Non-Brokered Private Placement For A Total Proceeds Of US$2,000,000

  October 16, 2014

   · 

  5 min read
• BioNet Provides Update on Recombinant Acellular Pertussis Vaccine at BioJapan 2014

  October 16, 2014

   · 

  1 min read
• Drug Development

  Allegro Ophthalmics LLC Begins Phase 2 Clinical Trial Of Luminate® (ALG-1001) For The Treatment Of Diabetic Macular Edema

  October 16, 2014

   · 

  1 min read
• Biotech Bay

  Sofie Biosciences Receives $1.5M National Cancer Institute Phase 2 SBIR

  October 16, 2014

   · 

  2 min read